Noble Financial
http://www.nobleresearch.com/index.htmNoble Financial is a capital markets firm. The firm provides private client services, equity research, sales and trading services, and investment banking services. The sectors in Noble’s coverage universe include healthcare services, media/entertainment, biotechnology, consumer, software, and business services.
View Older Stories View More Recent Stories
-
Streetinsider.com's Hot Lunchtime Reads 3/14: (TSLA) (GWPH) (HHS) (DDD)
-
Noble Financial Cuts PT on Harte-Hanks Inc. (HHS) to $5 Following Debt Facility, Dividend Elminiation
-
Avino arranges U.S. brokered public offering of shares
-
Noble Financial Affirms ICF Int'l (ICFI) at 'Hold'; Positive on 2016, Though Expectations Modest
-
Noble Financial Affirms XBiotech (XBIT) at 'Buy' Following EMA Approval to Submit Xilonix MAA
-
Noble Financial Affirms Engility (EGL) at 'Buy' Following Solid Q4 Results
-
Noble Financial Affirms Evoke Pharma (EVOK) at 'Buy' Following EVK-001 Phase 3 Update
-
Noble Reaffirms Entravision (EVC) at 'Buy'; Political Ads in Q1 Off to Good Start, Outlook Assume Trump as GOP Nominee
-
Streetinsider.com's Hot Lunchtime Reads 2/29: (COST) (SGMS) (SSP) (CRIS)
-
Noble Financial Trims PT on Scripps (SSP) to $25; Still See as Cheapest Stock in the Segment
-
Revive Therapeutics Ltd Announces Results for the Three and Six Months Ended December 31, 2015
-
Noble Trims PT on TherapeuticsMD (TXMD) to $17.50 Following Q4 Results; Affirms at 'Buy'
-
Noble Affirms BioCryst Pharma (BCRX) at 'Buy' Following Q4 Results; Two Oral HAE Programs Moving Forward
-
Noble Affirms Heron Therapeutics (HRTX) at 'Buy' Ahead of FDA Decision on Sustol; Pipeline Progress Highlighted
-
Noble Trims PT on Ciber (CBR) Amid Earnings Sell-Off; Sees Management Becoming 'More Aggressive'
-
Noble More Bullish on ManTech (MANT) for FY16; Reaffirms at 'Hold'
-
Noble Financial Sees Continued Growth Challenges for Guidance Software (GUID) in 2016; Affirms at 'Hold'
-
Streetinsider.com's Hot Lunchtime Reads 2/11: (BA) (TWTR) (ACOR) (EA)
-
Noble Financial Upgrades NCI, Inc. (NCIT) to Buy Following Q4 Results; Notes Improving Fundamentals
-
Lift of Partial Clinical Hold on Heat Biologics' (HTBX) HS-410 Much Earlier than Expected; Noble Reaffirms at 'Buy'
-
Noble Cuts PT on BioCryst (BCRX) to $8 Following OPuS-2 Data; Reaffirms at 'Buy'
-
Noble Sees Strong H216 for Amtech Systems (ASYS) Driven by Solar Orders; Affirms at 'Hold'
-
PRIVAIRA Announces Relocation of Operations at NobleCon12
-
CEL-SCI’s Chief Scientific Officer Discusses Cancer Immunotherapy Multikine
-
HDVideo Webcasts From NobleCon12 Available Friday, January 22, 2016 at 9:30am EST
-
Intelligent Building Technology ("IBT") to present at NobleCon 12
-
Intellipharmaceutics to Present at the Noble Financial Capital Markets’ 12th Annual Investor Conference
-
McClatchy Discusses Strategies And 2016 Outlook At Noble Emerging Growth Investor Conference
-
Enumeral to Present at the Noble Financial Capital Markets’ 12th Annual Investor and Equity Conference
-
RespireRx Pharmaceuticals Inc. to Present at Noble Financial Capital Markets' Twelfth Annual Investor/Equity Conference - NobleCon12
-
Revive Therapeutics to Present at Noble Capital Markets' Investor Conference
-
Blue Earth Announces the Attendance of the Noble Financials Capital Markets 12th Annual Emerging Growth Investor Conference
-
Aequus Pharmaceuticals to Present at Noble Capital Markets' Investor Conference
-
VBI Vaccines to Present at the Noble Financial Emerging Growth Investor Conference
-
Entravision Communications Corporation to Present at Noble Financial Capital Markets' 12th Annual Investor and Equity Conference
-
Avino production up 116% over 2014 to 3,020,348 oz silver equivalent
-
Agile Therapeutics to Present at Noble Financial Capital Markets’ Twelfth Annual Equity Conference
-
Noble Financial Positive on Prelim. LJPC-401 Phase 1 Data from La Jolla Pharma (LJPC); Reaffirms at 'Buy'
-
Delcath To Present At NobleCon12 Investor Conference
-
Avant Diagnostics to Attend 12th Annual Noble Capital Markets Conference
-
Energy Fuels to Present at NobleCon12 on Monday, January 18, 2016
-
ContraVir Pharmaceuticals to Present at NobleCon12
-
Eco-Stim Energy Solutions to Present at Noble Financial Capital Markets’ Twelfth Annual Investor Conference
-
Net Medical Xpress to Present at Noble Financial Capital Markets Conference
-
Recro Pharma to Present at NobleCon12 Investor Conference
-
Adgero Biopharmaceuticals to Present at Noble Financial Capital Markets' 12th Annual Investor Conference on January 18, 2016
-
Eyegate Pharmaceuticals to Present at the Noble Financial Capital Markets’ 12th Annual Investor Conference
-
Noble Financial Sees Harte-Hanks' (HHS) Near-Term Issues Being Resolved; Doesn't Rule Out Takeover
-
CEL-SCI Corporation to Present at the Noble Financial Capital Markets’ 12th Annual Investor Conference
-
Social Reality to Present at Noble Financial Capital Markets' 12th Annual Equity Conference

